Rare diseases
Investigational molecules
Locations
Fulham Road, SW3 6JJ, United Kingdom
The Royal Marsden NHS Foundation Trust is involved in clinical research focused on ER positive HER2 negative breast cancer, with particular attention to disease monitoring and treatment decisions guided by molecular evidence.
Its research activity in this area centres on identifying molecular signs of recurrence and evaluating endocrine-based treatment strategies for patients with detectable ctDNA during adjuvant therapy.
The Royal Marsden NHS Foundation Trust runs clinical trials in conditions such as Hormone receptor positive HER2 negative breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
